tiprankstipranks
Advertisement
Advertisement
Anteris Technologies: First U.S. patients treated in global PARADIGM trial
PremiumThe FlyAnteris Technologies: First U.S. patients treated in global PARADIGM trial
1M ago
Anteris Ends v2vmedtech Development Agreement, Limits Exposure
Premium
Company Announcements
Anteris Ends v2vmedtech Development Agreement, Limits Exposure
1M ago
Anteris Technologies secures CMS reimbursement for trial site activation
Premium
The Fly
Anteris Technologies secures CMS reimbursement for trial site activation
2M ago
Anteris Technologies initiated with an Overweight at Wells Fargo
PremiumThe FlyAnteris Technologies initiated with an Overweight at Wells Fargo
3M ago
Anteris Technologies reports FY25 R&D expenses $69.1M
Premium
The Fly
Anteris Technologies reports FY25 R&D expenses $69.1M
4M ago
Anteris Technologies price target lowered to $17 from $22 at Barclays
Premium
The Fly
Anteris Technologies price target lowered to $17 from $22 at Barclays
4M ago
Anteris Technologies Announces Major Equity Offering and Medtronic Deal
PremiumCompany AnnouncementsAnteris Technologies Announces Major Equity Offering and Medtronic Deal
5M ago
Anteris Technologies 34.8M share Spot Secondary priced at $5.75
Premium
The Fly
Anteris Technologies 34.8M share Spot Secondary priced at $5.75
5M ago
Anteris Technologies announces $200M common stock offering
Premium
The Fly
Anteris Technologies announces $200M common stock offering
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100